BioCryst Pharmaceuticals (BCRX)
(Real Time Quote from BATS)
$7.53 USD
-0.10 (-1.31%)
Updated Sep 25, 2024 02:36 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (87 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.36 | 1.58 | 9.99 |
Current Quarter Estimate | -0.07 | -1.06 | 61.00 |
Year Ago Quarter Estimate | -0.19 | -0.06 | 54.84 |
Next Quarter Estimate | -0.09 | -1.85 | 63.00 |
Next Year Estimate | -0.20 | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 62.00 | 20.20 | 15.67 |
Next Year | 47.37 | 15.90 | 11.34 |
Last 5 Years | -386.40 | 7.80 | 8.10 |
Next 5 Years | 40.40 | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.82 |
Price/Book (MRQ) | NA | 1.65 |
Price/Cash Flow (MRFY) | NA | 8.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -38.18% | -58.89% |
Return on Equity (TTM) | NA | -58.88% |
Debt to Equity (MRQ) | -1.70 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.